Health predicts insulin distribution next week – 06/23/2023 – Health

The Ministry of Health signed a contract, this Tuesday (20), for the acquisition of 473,000 fast-acting insulin analogues for the treatment of people living with diabetes. The forecast is that the shipment will be distributed to all states and the Federal District starting next week.

The folder said, in a note, that the company Novo Nordisk can deliver the product within 60 days after the signing of the contract by the trading floor rule. However, given the difficulty in acquiring the medication and the risk of shortages, there was a request for an early delivery.

A Sheet revealed that there could be a lack of insulin for diabetes in the states because the ministry’s stock would run out in April. In May, there was already a shortage of the product in some states.

The more than 400,000 doses of insulin will complement the network’s supply, along with the 1.3 million doses of the international emergency acquisition that had a contract signed in May. This shipment is expected to be delivered by July 9th.

Fast-acting insulin analogues were incorporated into the SUS in 2017 after approval by Conitec (National Commission for the Incorporation of Technologies in the Unified Health System).

Societies and medical entities and representatives of people with diabetes do not recommend replacing analogue insulin with regular human insulin, which may increase the risk of severe and nocturnal hypoglycemia, for example.

Such as Sheet showed, the risk of shortages was warned by the TCU (Union Court of Auditors) and occurred because there were no proposals in the open trading sessions in August of last year and in January of this year.

The Ministry of Health told TCU that, given the failure of the bids carried out during the Bolsonaro government, it opted to carry out the emergency direct purchase of the product, in January of this year, to prevent shortages.